[1]冯倩倩 郑春玲 王丽丽 何疆春.人工智能辅助高血压管理的研究现状与应用前景[J].心血管病学进展,2025,(9):774.[doi:10.16806/j.cnki.issn.1004-3934.2025.09.002]
　FENG Qianqian,WANG Lili,HE Jiangchun.Research Status and Application Prospect of Artificial Intelligence i n Hypertension Management[J].Advances in Cardiovascular Diseases,2025,(9):774.[doi:10.16806/j.cnki.issn.1004-3934.2025.09.002]
点击复制

人工智能辅助高血压管理的研究现状与应用前景()

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年9期
页码:
774
栏目:
综述
出版日期:
2025-09-25

文章信息/Info

Title:
Research Status and Application Prospect of Artificial Intelligence i n Hypertension Management
作者:
冯倩倩 郑春玲 王丽丽 何疆春
(中国人民解放军总医院第六医学中心心血管病医学部,北京 100048)
Author(s):
FENG Qianqian; WANG Lili; HE Jiangchun
(Department of Cardiovascular Medicine,Sixth Medical Center,Chinese PLA General Hospital,Beijing 100048,China)
关键词:
人工智能; 高血压管理; 早期筛查; 个体化治疗方案
Keywords:
Artificial intelligence; Hypertension management; Early screening; Personalized treatment plan
DOI:
10.16806/j.cnki.issn.1004-3934.2025.09.002
摘要:
高血压作为一种全球范围内广泛存在的慢性疾病，对人类的健康及生活质量构成严重威胁，因此，高血压管理始终是公共卫生领域的一大核心议题。人工智能（AI）技术飞速发展，其在医疗健康领域的应用不断涌现，为高血压管理带来了新机遇。当前AI技术在高血压早期筛查、个体化治疗、患者教育与自我管理、远程监测以及数据分析等领域已取得显著进展。传统管理方法与现代技术相融合，展现出卓越成效。然而，在实际应用中，数据隐私、技术整合和临床验证等方面仍面临重大挑战。现总结AI在高血压管理方面的应用现状，探究其未来的发展前景。
Abstract:
Hypertension,as a widespread chronic disease globally,poses a serious threat to human health and quality of life. Therefore,the hypertension management has always been a core issue in the field of public health. The rapid development of artificial intelligence(AI) technology and its continuous emergence in the field of healthcare have brought new opportunities for hypertension management. Current AI technolog y have made significant progress in areas such as early screening for hypertension,personalized treatment,patient education and self-management,remote monitoring and data analysis. The integration of traditional management methods with modern technology has demonstrated remarkable effectiveness. However,in practical applications,significant challenges remain in areas such as data privacy,technology integration and clinical validation. This article summarizes the current applications of AI in hypertension management and explores its future development prospects.

参考文献/References:

[1] Layton AT. AI,machine learning,and ChatGPT in hypertension[J]. Hypertension,2024,81(4):709-716.

[2] Huang AA,Huang SY. Shapely additive values can effectively visualize pertinent covariates in machine learning when predicting hypertension[J]. J Clin Hypertens(Greenwich),2023,25(12):1135-1144.

[3] Alam SF,Gonzalez Suarez ML. Transforming healthcare:the AI revolution in the comprehensive care of hypertension[J]. Clin Pract,2024,14(4):1357-1374.

[4] Tsoi K,Yiu K,Lee H,et al. Applications of artificial intelligence for hypertension management[J]. J Clin Hypertens(Greenwich),2021,23(3):568-574.

[5] Chowdhury MZI,Leung AA,Walker RL,et al. A comparison of machine learning algorithms and traditional regression-based statistical modeling for predicting hypertension incidence in a Canadian population[J]. Sci Rep,2023,13(1):13.

[6] Shimbo D,Shah RU,Abdalla M,et al. Transforming hypertension diagnosis and management in the era of artificial intelligence:a 2023 National Heart,Lung, and Blood Institute(NHLBI) workshop report[J]. Hypertension ,2025,82(1):36-45.

[7] Visco V,Izzo C,Mancusi C,et al. Artificial intelligence in hypertension management:an ace up your sleeve[J]. J Cardiovasc Dev Dis,2023,10(2):74.

[8] Kengne AP,Brière JB,Gudi?a IA,et al. The impact of non-pharmacological interventions on adherence to medication and persistence in dyslipidaemia and hypertension:a systematic review[J]. Expert Rev Pharmacoecon Outcomes Res,2024,24(7):807-816.

[9] Yukselen Z,Singh Y,Malempati S,et al. Virtual patient education for hypertension:the truth about behavioral change[J]. World J Cardiol,2023,15(6):324-327.

[10] Sun T,Xu X,Ding Z,et al. Development of a health behavioral digital intervention for patients with hypertension based on an intelligent health promotion system and WeChat:Randomized controlled trial[J]. JMIR Mhealth Uhealth,2024,12:e53006.

[11] Lai WX,Visaria A,?stbye T,et al. Prevalence and correlates of use of digital technology for managing hypertension among older adults[J]. J Hum Hypertens,2023,37(1):80-87.

[12] Dhar E,Upadhyay U,Huang Y,et al. A scoping review to assess the effects of virtual reality in medical education and clinical care[J]. Digit Health,2023,9:20552076231158022.

[13] Chen P,Li Y,Zhang X,et al. The acceptability and effectiveness of artificial intelligence-based chatbot for hypertensive patients in community:protocol for a mixed-methods study[J]. BMC Public Health,2024,24(1):2266.

[14] Zhang GW,Li B,Gu ZM,et al. In-depth examination of the functionality and performance of the internet hospital information platform:development and usability study[J]. J Med Internet Res,2024,26:e54018.

[15] Layton AT. Artificial Intelligence and machine learning in preeclampsia[J]. Arterioscler Thromb Vasc Biol,2025,45(2):165-171.

[16] Alhammad N,Alajlani M,Abd-Alrazaq A,et al. Patients’ perspectives on the data confidentiality,privacy,and security of m Health Apps:systematic review[J]. J Med Internet Res,2024,26:e50715.

[17] Khalid N,Qayyum A,Bilal M,et al. Privacy-preserving artificial intelligence in healthcare:techniques and applications[J]. Comput Biol Med,2023,158:106848.

[18] Zondag AGM,Rozestraten R,Grimmelikhuijsen SG,et al. The effect of artificial intelligence on patient-physician trust:cross-sectional vignette study[J]. J Med Internet Res,2024,26:e50853.

[19] Redrup Hill E,Mitchell C,Brigden T,et al. Ethical and legal considerations influencing human involvement in the implementation of artificial intelligence in a clinical pathway:a multi-stakeholder perspective[J]. Front Digit Health ,2023,5:1139210.

[20] Dzau VJ,Hodgkinson CP. Precision hypertension[J]. Hypertension,2024,81(4):702-708.

[21] Jegan R,Nimi WS. On the development of low power wearable devices for assessment of physiological vital parameters:a systematic review[J]. Z Gesundh Wiss,2023:1-16.

[22] Vo TS,Hoang T,Vo TTBC,et al. Recent trends of bioanalytical sensors with smart health monitoring systems:from materials to applications[J]. Adv Healthc Mater,2024,13(17):e2303923.

[23] Son YS,Kwon KH. Utilization of smart devices and the evolution of customized healthcare services focusing on big data:a systematic review[J]. Mhealth,2023,10:7.

[24] Manzi G,Miotti C,Mariani MV,et al. Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension[J]. J Clin Med,2021,11(1):82.

相似文献/References:

[1]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[2]袁佳栎 王群山.人工智能在心律失常诊断中的前景与挑战[J].心血管病学进展,2020,(10):999.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.001]
　YUAN JialiWANG Qunshan.Prospects and Challenges of Arrhythmia Diagnosis by Artificial Intelligence[J].Advances in Cardiovascular Diseases,2020,(9):999.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.001]
[3]沈文茜 杜国庆.机器学习在超声心动图中的应用进展[J].心血管病学进展,2021,(1):43.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
　SHEN Wenqian,DU Guoqing.Machine Learning in Echocardiography[J].Advances in Cardiovascular Diseases,2021,(9):43.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[4]王苏淮 李晶洁.机器学习在心血管疾病中的临床应用进展[J].心血管病学进展,2021,(2):144.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.013]
　WANG Suhuai,LI Jingjie.Clinical Applications of Machine Learning in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2021,(9):144.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.013]
[5]兰贝蒂 王瑞涛.人工智能及3D打印技术在心血管疾病诊疗中的应用进展[J].心血管病学进展,2021,(4):292.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.002]
　LAN Beidi,WANG Ruitao.Application Progress of Artificial Intelligence and 3D Printing Technology in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2021,(9):292.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.002]
[6]王继航 田进文 王建 郭毅 周星儿 付振虹 沈明志 刘亮.基于人工智能可穿戴设备及物联网的胸痛区域平台研究进展[J].心血管病学进展,2021,(6):492.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.004]
　WANG JihangTIAN JinwenWANG JianGUO YiZHOU XingerGUO utingFU ZhenhongSHEN MingzhiLIU Liang.Chest Pain Area Platform based on Artificial Intelligence Wearable Devices and Internet of Things[J].Advances in Cardiovascular Diseases,2021,(9):492.[doi:10.16806/j.cnki.issn.1004-3934.2021.06.004]
[7]黄佳星 王猛 江洪.人工智能神经活性分析研究进展[J].心血管病学进展,2022,(6):538.[doi:10.16806/j.cnki.issn.1004-3934.20.06.015]
　HUANG JiaxingWANG MengJIANG Hong.Artificial Intelligence and Neural Activity Analysis[J].Advances in Cardiovascular Diseases,2022,(9):538.[doi:10.16806/j.cnki.issn.1004-3934.20.06.015]
[8]孜拉来·艾尼瓦尔 周贤惠.无症状性心房颤动检测设备的研究进展[J].心血管病学进展,2022,(7):624.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
　Zilalai AiniwarZHOU Xianhui.Detection Devices of Asymptomatic Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(9):624.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[9]陈忠秀 李娅姣 李春梅 李晨.无导丝虚拟血流储备分数技术在稳定性冠心病介入治疗中的指导价值[J].心血管病学进展,2022,(10):865.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.001]
　CHEN Zhongxiu,LI Yajiao,LI Chunmei,et al.The Value of Wireless Virtual Fractional Flow Reserve in Guiding Percutaneous Coronary Intervention in Stable Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2022,(9):865.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.001]
[10]秦地茂 李梦依 吴霜 邓祁 姚尧 刘英杰 郑颖.人工智能在心房颤动预测中的价值[J].心血管病学进展,2022,(10):874.[doi:10.16806/j.issn.1004-3934.2022.10.003]
　QIN Dimao,LI Mengyi,WU Shuang,et al.Artificial Intelligence for Predicting Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(9):874.[doi:10.16806/j.issn.1004-3934.2022.10.003]

更新日期/Last Update: 2025-12-18